What is OrthoPediatrics's market cap?

OrthoPediatrics (KIDS) has a market capitalization of $509.1M and trades on NASDAQ.

What is OrthoPediatrics's revenue and profitability?

OrthoPediatrics generated $243.3M in trailing twelve-month revenue with a net loss of $39.7M, representing a net margin of -16.3%. Gross margin stands at 73.1%, with free cash flow of -$30.8M. These figures are based on the Q1 2026 filing.

Who are OrthoPediatrics's competitors?

OrthoPediatrics's key competitors include Orthofix, Stryker Corporation, Zimmer Biomet, and others. These companies compete in similar markets and product categories.

Who does OrthoPediatrics partner with?

OrthoPediatrics's notable partners include Squadron, Braidwell LP, Ora Medical, and others.

What subsidiaries does OrthoPediatrics have?

OrthoPediatrics's subsidiaries include ApiFix, Ltd., MD Ortho, Pega Medical, and others.

Where is OrthoPediatrics headquartered?

OrthoPediatrics is headquartered in United States of America and employs approximately 247 people. It has been publicly traded since 2017.

OrthoPediatrics

KIDS

OrthoPediatrics is a global medical device company focused exclusively on the pediatric orthopedic market, addressing the unique skeletal anatomy and physiological needs of children.

Market cap

$509.08M-5.2%

Revenue$243.3M+14.5%

Net income-$39.7M+2.5%

Free cash flow-$30.8M+25.6%

EPS (diluted)-$1.68+4.6%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 30, 2026

Revenue$59.4MBeat by $1.1M EPS-$0.42Miss by $0.04

Read the full report

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$68.2M

EPS estimate-$0.31

Financials

Q1 2026

Income statement

See full

Revenue$59.4M+13.3%

Gross profit$43.4M+13.4%

Operating income-$8.3M+24.1%

Net income-$10.7M-0.3%

EPS (diluted)-$0.45+2.2%

Balance sheet

See full

Cash & equivalents$14.2M-59.8%

Total debt$5.4M+271%

Total equity$338.7M-2.4%

Total assets$502.2M+6.8%

Cash flow

See full

Operating cash flow-$3.3M+20.9%

CapEx$1.8M-58.4%

Free cash flow-$5.0M+39.8%

Valuation & ratios

Valuation

See full

Market cap$509.08M-5.2%

Enterprise value$500.24M-1.8%

P/S2.1×-0.4×

Profitability

See full

Gross margin73.1%+0.3pp

Operating margin-15%-1.6pp

Net margin-16.3%-2.1pp

Returns & leverage

See full

Return on equity-11.6%+0.2pp

Debt / equity0×0.0×

Current ratio5.2×-1.0×

Segments

By product

See full

Trauma and deformity$43.0M+13.7%

Scoliosis$15.4M+13.0%

Sports medicine/other$875.0K-0.6%

Competitors

By market cap

Johnson & Johnson$640.91B+60.1%

Stryker$129.09B-15.7%

Medtronic$107.81B-8.5%

Zimmer Biomet Holdings$17.8B-6.2%

Globus Medical$10.6B+44.5%

OrthoPediatrics$509.1M-8.2%

Orthofix Medical Inc.$481.0M+7.7%

Treace Medical Concepts, Inc.$264.7M-26.8%

By revenue growth

Globus Medical+23.5%

OrthoPediatrics+14.5%

Zimmer Biomet Holdings+9.2%

Stryker+8.8%

Medtronic+8.4%

Johnson & Johnson+8.1%

Orthofix Medical Inc.+2.6%

Treace Medical Concepts, Inc.-1.7%

By net margin

Johnson & Johnson21.48%-3.5pp

Globus Medical18.92%+11.5pp

Stryker13.21%+0.9pp

Medtronic13.2%-0.7pp

Zimmer Biomet Holdings9.05%-2.8pp

Orthofix Medical Inc.-7.27%+10.5pp

OrthoPediatrics-16.31%+2.8pp

Treace Medical Concepts, Inc.-29.44%-4.3pp

Profile

OrthoPediatrics is a global medical device company focused exclusively on the pediatric orthopedic market, addressing the unique skeletal anatomy and physiological needs of children. The company designs, develops, and commercializes anatomically appropriate implants, instruments, and specialized bracing products for trauma, deformity correction, scoliosis, and sports medicine. Its value proposition centers on providing pediatric-specific solutions to a market historically underserved by adult-focused orthopedic manufacturers.

Competitive position

The company is the only global medical device firm focused exclusively on the pediatric orthopedic market, holding a leading position through the broadest product portfolio in its niche.

GeographiesUnited States, United Kingdom, Australia, New Zealand, Canada, European Union, Brazil

Customer segmentsChildren's Hospitals, Ambulatory Surgery Centers, Pediatric Surgeons

Business modelManufacturing, Direct Sales, Clinical Services, Licensing

SuppliersThird-party contract manufacturers, Raw material suppliers, Specialized technology licensors

CustomersHigh-volume children's hospitals, Ambulatory surgery centers, Independent stocking distributors, Pediatric orthopedic surgeons

CountryUnited States of America

Listed2017

Employees247.0

CEODavid R. Bailey

SectorHealthcare

IndustryMedical - Devices

Websiteorthopediatrics.com

FilingsSEC EDGAR

Ask your AI about OrthoPediatrics.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OrthoPediatrics's market cap?: OrthoPediatrics (KIDS) has a market capitalization of $509.1M and trades on NASDAQ.
What is OrthoPediatrics's revenue and profitability?: OrthoPediatrics generated $243.3M in trailing twelve-month revenue with a net loss of $39.7M, representing a net margin of -16.3%. Gross margin stands at 73.1%, with free cash flow of -$30.8M. These figures are based on the Q1 2026 filing.
Who are OrthoPediatrics's competitors?: OrthoPediatrics's key competitors include Orthofix, Stryker Corporation, Zimmer Biomet, and others. These companies compete in similar markets and product categories.
Who does OrthoPediatrics partner with?: OrthoPediatrics's notable partners include Squadron, Braidwell LP, Ora Medical, and others.
What subsidiaries does OrthoPediatrics have?: OrthoPediatrics's subsidiaries include ApiFix, Ltd., MD Ortho, Pega Medical, and others.
Where is OrthoPediatrics headquartered?: OrthoPediatrics is headquartered in United States of America and employs approximately 247 people. It has been publicly traded since 2017.